PepGen Inc. (PEPG)
3.15
-0.06
(-1.87%)
USD |
NASDAQ |
Sep 09, 15:46
PepGen Total Liabilities (Quarterly) : 21.86M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.86M |
| March 31, 2026 | 22.32M |
| December 31, 2025 | 26.46M |
| September 30, 2025 | 26.92M |
| June 30, 2025 | 31.08M |
| March 31, 2025 | 35.59M |
| December 31, 2024 | 32.26M |
| September 30, 2024 | 32.78M |
| June 30, 2024 | 38.47M |
| March 31, 2024 | 28.00M |
| December 31, 2023 | 34.63M |
| September 30, 2023 | 38.41M |
| Date | Value |
|---|---|
| June 30, 2023 | 34.80M |
| March 31, 2023 | 36.20M |
| December 31, 2022 | 37.81M |
| September 30, 2022 | 15.52M |
| June 30, 2022 | 20.58M |
| March 31, 2022 | 16.29M |
| December 31, 2021 | 10.55M |
| September 30, 2021 | 9.479M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.868M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.40M |
| Shareholders Equity (Quarterly) | 119.53M |
| Debt to Equity Ratio | 0.1346 |
| Current Ratio | 13.36 |
| Net Debt Paydown Yield | 0.35% |